← 治験一覧に戻る
ソナゾイドを用いた肝臓がん早期発見のための臨床試験
基本情報
- NCT ID
- NCT00822991
- ステータス
- 不明
- 試験のフェーズ
- 該当なし
- 試験タイプ
- 介入
- 目標被験者数
- 760
- 治験依頼者名
- Kindai University
概要
The aim of this study is to prove usefulness of contrast-enhanced ultrasound (CE-US) using Sonazoid (TM) in the early detection of HCC as compared with conventional B-mode ultrasound (B-mode US) for hepatitis virus related cirrhosis, who are defined as super high-risk patients for hepatocarcinogenesis,Furthermore, to analyze whether early detection of HCC by CE-US has a survival benefit than that by B-mode US.
対象疾患
Hepatocellular CarcinomaLiver CirrhosisHepatitis BHepatitis C
介入
CE-US (Sonazoid™)(DEVICE)
B-mode US(DEVICE)
依頼者（Sponsor）
Kindai University(OTHER)
実施施設 (1)
近畿大学東洋医学研究所附属診療所
Ōsaka-sayama, Osaka, Japan(RECRUITING)